Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.

Saved in:

Bibliographic Details
Title:	Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses.
Authors:	Brodowicz, T¹, Lang, I², Kahan, Z³, Greil, R⁴, Beslija, S⁵, Stemmer, S M⁶, Kaufman, B⁷, Petruzelka, L⁸, Eniu, A⁹, Anghel, R¹⁰, Koynov, K¹¹, Vrbanec, D¹², Pienkowski, T¹³, Melichar, B¹⁴, Spanik, S¹⁵, Ahlers, S¹⁶, Messinger, D¹⁶, Inbar, M J¹⁷, Zielinski, C¹
Source:	British Journal of Cancer. 11/25/2014, Vol. 111 Issue 11, p2051-2057. 7p. 4 Charts, 2 Graphs.
Database:	Academic Search Ultimate

Description
ISSN:	00070920
DOI:	10.1038/bjc.2014.504